$ONCS ONCOSEC MEDICAL Inc Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ONCOSEC MEDICAL Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ONCOSEC MEDICAL Inc. Insider overview, share value development, latest insider transactions and email notifications about new events in ONCOSEC MEDICAL Inc for free.
IRS Number: 980573252
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ONCS
Company Address: 24 N. MAIN STREET PENNINGTON 08534
Phone number: 855-662-6732
Former name: NetVentory Solutions, Inc., date of change: 2008-09-02
Market Capitalization: $22.69M
Prev close: $1.15
Average Daily Volume: 138,760
Days Low: $1.15
Year Low: $1.03
Year High: $3.49
ONCOSEC MEDICAL Inc Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2021 | ONCS | ONCOSEC MEDICAL In ... | Smith Kevin Raymond Merrill | Director | Option Exercise | A | 3.16 | 25,000 | 79,000 | 25,000 | |
| Jun 29 2021 | ONCS | ONCOSEC MEDICAL In ... | Zhou Chao | Director | Option Exercise | A | 3.16 | 25,000 | 79,000 | 25,000 | |
| Jun 29 2021 | ONCS | ONCOSEC MEDICAL In ... | Ward Robert | Director | Option Exercise | A | 3.16 | 25,000 | 79,000 | 25,000 | |
| Jun 29 2021 | ONCS | ONCOSEC MEDICAL In ... | Ward Robert | Director | Option Exercise | A | 3.16 | 25,000 | 79,000 | 25,000 | |
| May 04 2021 | ONCS | ONCOSEC MEDICAL In ... | DelAversano Robert J | VP, Finance | Sell | S | 4.86 | 453 | 2,202 | 24,980 | 25.4 K to 25 K (-1.78 %) |
| May 04 2021 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 4.86 | 3,172 | 15,416 | 96,097 | 99.3 K to 96.1 K (-3.20 %) |
| Apr 26 2021 | ONCS | ONCOSEC MEDICAL In ... | China Grand Pharmaceutical & H ... | 10% Owner | Buy | P | 3.45 | 281,968 | 972,790 | 3,359,607 | 3.1 M to 3.4 M (+9.16 %) |
| Apr 26 2021 | ONCS | ONCOSEC MEDICAL In ... | China Grand Pharmaceutical & H ... | 10% Owner | Buy | P | 3.45 | 1,409,838 | 4,863,941 | 16,798,036 | 15.4 M to 16.8 M (+9.16 %) |
| Feb 23 2021 | ONCS | ONCOSEC MEDICAL In ... | Alpha Holdings, Inc. | Director | Option Exercise | X | 3.45 | 368,250 | 1,270,463 | 0 | |
| Feb 23 2021 | ONCS | ONCOSEC MEDICAL In ... | Alpha Holdings, Inc. | Director | Buy | X | 3.45 | 368,250 | 1,270,463 | 1,718,251 | 1.4 M to 1.7 M (+27.28 %) |
| Feb 17 2021 | ONCS | ONCOSEC MEDICAL In ... | Leuthner Brian A | Chief Operating Off ... | Option Exercise | A | 7.45 | 150,000 | 1,117,500 | 150,000 | |
| Feb 03 2021 | ONCS | ONCOSEC MEDICAL In ... | DelAversano Robert J | Principal Accountin ... | Grant | A | 0.00 | 8,750 | 0 | 25,433 | 16.7 K to 25.4 K (+52.45 %) |
| Feb 02 2021 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 7.71 | 3,413 | 26,314 | 99,269 | 102.7 K to 99.3 K (-3.32 %) |
| Jan 27 2021 | ONCS | ONCOSEC MEDICAL In ... | China Grand Pharmaceutical & H ... | 10% Owner | Buy | P | 5.45 | 677,839 | 3,694,223 | 3,077,639 | 2.4 M to 3.1 M (+28.25 %) |
| Jan 27 2021 | ONCS | ONCOSEC MEDICAL In ... | China Grand Pharmaceutical & H ... | 10% Owner | Buy | P | 5.45 | 3,389,198 | 18,471,129 | 15,388,198 | 12 M to 15.4 M (+28.25 %) |